Abstract
At present, there are no specific nationwide epidemiological studies representing the whole Italian population. This study is aimed at describing the epidemiological and economic burden that HCV will generate in the next few years in Italy. Furthermore, the impact that future anti-HCV treatments may have on the burden of disease was considered. This analysis was developed for the period 2012-2030 from the perspective of the Italian National Health Service (NHS).
| Original language | English |
|---|---|
| Pages (from-to) | 303-310 |
| Number of pages | 8 |
| Journal | ClinicoEconomics and Outcomes Research |
| Volume | 6 |
| Issue number | Giugno |
| DOIs | |
| Publication status | Published - 2014 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Economics, Econometrics and Finance (miscellaneous)
- Health Policy
Keywords
- chronic hepatitis
- cost of illness
- forecast
- new HCV treatment
Fingerprint
Dive into the research topics of 'Health policy model: long-term predictive results associated with the management of hepatitis C virus-induced diseases in Italy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver